Clinical Biochemical Genetics · New York, NY
NPI
1023066198
Since 2006
Specialty
Clinical Biochemical Genetics
Code 207SG0202X
Group practices
2
Medicare group memberships
Hospitals
0
Hospital affiliations
1 Gustave L Levy Pl, Box 1497
New York, NY, 10029
Phone (212) 241-2478
Groups this clinician bills Medicare through
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$1.0M
22 prescriptions
Company payments, 2025
$9,881
From 4 companies
Medicare prescription drug claims, 2024
In 2024, the drug Melissa P Wasserstein prescribed most often to Medicare patients was Dojolvi (Triheptanoin), with 11 prescriptions and refills. In total Melissa P Wasserstein wrote 22 Medicare prescriptions that cost $1.0M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2011-04-13.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Dojolvi Triheptanoin | 11 | 11 | Under 11 | $336K |
Brand drugs: 22 claims; generic drugs: 0 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Melissa P Wasserstein $9,881 ($6,631 in general payments such as food, travel and fees and $3,250 for research) from 4 companies. The largest payer was Genzyme Corporation with $9,767.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.